Prehospital whole blood in traumatic hemorrhage — A randomized controlled trial (Registro nro. 22767)

000 -Cabecera
Campo de control interno 02958nam a2200301 4500
001 - Número de control
control field ESSALUD
005 - Fecha y hora de la última transacción
Campo de control 20260805092312.0
007 - Tipo material - Descripcion fisica - info general
Tipo material - Descripcion fisica - info general ta
008 - Elementos de Longitud Fija - Información General
Elementos de Longitud Fija - Información t pe ||||| |||| 00| 0 spa d
040 ## - Origen de la Catalogación
Origen de la Catalogación BMG
041 ## - Idioma
Idioma eng
100 ## - Autor
Autor Smith, Jason E.
Rol del Autor Autor
9 (RLIN) 53902
245 ## - Titulo
Titulo Prehospital whole blood in traumatic hemorrhage — A randomized controlled trial
300 ## - Páginas
Paginación páginas: 2305-2316
520 ## - Resumen
Resumen Background: Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking.<br/>Methods: We conducted a pragmatic, phase 3, multicenter, unblinded, randomized, superiority trial across 10 air ambulance services in England. Patients with major traumatic hemorrhage who were attended by a participating air ambulance service were randomly assigned to receive either whole-blood transfusion (up to 2 units) or standard care with blood components (up to 2 units each of red cells and plasma) before arrival at the hospital. The primary outcome was a composite of death from any cause or massive transfusion (≥10 units of blood components or products) within 24 hours after randomization.<br/>Results: A total of 942 patients underwent randomization. After the exclusion of participants with nontraumatic hemorrhage or traumatic cardiac arrest, 616 were included in the analysis (314 in the whole-blood group and 302 in the standard-care group). A primary-outcome event occurred in 48.7% of the participants in the whole-blood group and in 47.7% of those in the standard-care group (relative risk, 1.02; 95% confidence interval, 0.80 to 1.31; P=0.84). The incidence of death from any cause at all time points, massive transfusion, and other secondary outcomes appeared to be similar in the two groups. Prothrombin times were above the normal range in 40.7% of the participants in the whole-blood group and in 30.5% of those in the standard-care group. More serious adverse events occurred in the standard-care group than in the whole-blood group (37 and 31, respectively). The incidence of thrombotic events appeared to be similar in the two groups.<br/>Conclusions: Among participants with life-threatening hemorrhage, prehospital transfusion of 2 units of whole blood was not superior to standard care in reducing the risk of death or massive transfusion within 24 hours.
650 ## - Temas - Descriptores
Temas - Descriptores NEUMOLOGÍA
9 (RLIN) 25628
650 ## - Temas - Descriptores
Temas - Descriptores COAGULACIÓN
9 (RLIN) 53903
650 ## - Temas - Descriptores
Temas - Descriptores CUIDADOS INTENSIVOS
9 (RLIN) 5208
650 ## - Temas - Descriptores
Temas - Descriptores MEDICINA DE URGENCIAS
9 (RLIN) 53820
650 ## - Temas - Descriptores
Temas - Descriptores HEMATOLOGÍA
9 (RLIN) 7422
700 ## - Autor Personal
Autor Personal Cardigan, Rebecca
9 (RLIN) 53904
700 ## - Autor Personal
Autor Personal Sanderson, Emily
9 (RLIN) 53905
700 ## - Autor Personal
Autor Personal Silsby, Laura
9 (RLIN) 53906
700 ## - Autor Personal
Autor Personal Rourke, Claire
9 (RLIN) 53907
700 ## - Autor Personal
Autor Personal Basham, Peter
9 (RLIN) 53908
773 0# - Revista (Relacion con el numero)
Host Biblionumber 22717
Host Itemnumber 22640
Ciudad, Editorial Massachusetts NEJM Group
Codigo barras item/ejemplar NEJM007
Titulo de la Revista The New England Journal of Medicine
Número de control de registro ESSALUD
ISSN 0028-4793
942 ## - Elementos de Koha
Tipo de Documento Artículos
Fecha procesamiento 2026-08-03
Catalogador SQB

No hay ítems disponibles.